Safety and Pharmacokinetics of a Novel Formulation of Human Apolipoprotein A-I (CSL112) in Healthy Subjects: Results of a Placebo-Controlled, Randomized Multiple Ascending Dose Study

被引：0
|
作者：
Easton, Rachael [1 ]
Tremper, Louise [2 ]
Shear, Charles [1 ]
机构：
[1] CSL Behring, King Of Prussia, PA USA
[2] CSL Ltd, Clin Study Management, Parkville, Vic, Australia
来源：
CIRCULATION | 2012年 / 126卷 / 21期
关键词：
Acute coronary syndromes; Apolipoproteins; HDL elevating therapies; Pharmacokinetics; Clinical trials;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
11892
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A phase I, randomized, double-blind, placebo-controlled, ascending single- and multiple-dose study of the pharmacokinetics, safety, and tolerability of oral ceftibuten in healthy adult subjects
    Hernandez-Mitre, Maria Patricia
    Wallis, Steven C.
    Morgan, Elizabeth E.
    Dudley, Michael N.
    Loutit, Jeffery S.
    Griffith, David C.
    Roberts, Jason A.
    Shields, Ryan K.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2024, 68 (01)
  • [22] Effect of CSL112 (apolipoprotein A-I [human]) on cholesterol efflux capacity in Japanese subjects: Findings from a phase I study and a cross-study comparison
    Zheng, Bo
    Goto, Shinya
    Clementi, Regina
    Feaster, John
    Duffy, Danielle
    Dalitz, Penelope
    Airey, Jolanta
    Korjian, Serge
    Tortorici, Michael A.
    Roberts, John
    Gibson, C. Michael
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2022, 15 (10): : 2331 - 2341
  • [23] Evaluation of potential antiplatelet effects of CSL112 (Apolipoprotein A-I [Human]) in patients with atherosclerosis: results from a phase 2a study
    Gurbel, Paul A.
    Tantry, Udaya S.
    D'Andrea, Denise
    Chung, Thomas
    Alexander, John H.
    Bliden, Kevin P.
    Wright, Samuel D.
    Tricoci, Pierluigi
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2018, 45 (04) : 469 - 476
  • [24] A Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Avagacestat (BMS-708163) in Healthy Young and Elderly Subjects
    Dockens, Randy
    Wang, Jun-Sheng
    Castaneda, Lorna
    Sverdlov, Oleksandr
    Huang, Shu-Pang
    Slemmon, Randy
    Gu, Huidong
    Wong, Oi
    Li, Hewei
    Berman, Robert M.
    Smith, Christina
    Albright, Charles F.
    Tong, Gary
    CLINICAL PHARMACOKINETICS, 2012, 51 (10) : 681 - 693
  • [25] A Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Avagacestat (BMS-708163) in Healthy Young and Elderly Subjects
    Randy Dockens
    Jun-Sheng Wang
    Lorna Castaneda
    Oleksandr Sverdlov
    Shu-Pang Huang
    Randy Slemmon
    Huidong Gu
    Oi Wong
    Hewei Li
    Robert M. Berman
    Christina Smith
    Charles F. Albright
    Gary Tong
    Clinical Pharmacokinetics, 2012, 51 : 681 - 693
  • [26] CSL112 (APOLIPOPROTEIN A-I [HUMAN]) SIMILARLY ENHANCES CHOLESTEROL EFFLUX CAPACITY IN JAPANESE AND CAUCASIAN SUBJECTS: FINDINGS FROM A PHASE 1 STUDY
    Tortorici, Michael
    Clementi, Regina
    Feaster, John
    Zheng, Bo
    Duffy, Danielle
    Dalitz, Penelope
    Airey, Jolanta
    Roberts, John
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 131 - 131
  • [27] A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
    Lesley Taylor
    Barry Gidal
    Graham Blakey
    Bola Tayo
    Gilmour Morrison
    CNS Drugs, 2018, 32 : 1053 - 1067
  • [28] A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
    Taylor, Lesley
    Gidal, Barry
    Blakey, Graham
    Tayo, Bola
    Morrison, Gilmour
    CNS DRUGS, 2018, 32 (11) : 1053 - 1067
  • [29] Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Alirocumab in Healthy Chinese Subjects: A Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study
    Haiyan Li
    Yudong Wei
    Zhenhua Yang
    Shuang Zhang
    Xiuxiu Xu
    Mengmeng Shuai
    Olivier Vitse
    Yiwen Wu
    Marie T. Baccara-Dinet
    Yi Zhang
    Jianyong Li
    American Journal of Cardiovascular Drugs, 2020, 20 : 489 - 503
  • [30] Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Alirocumab in Healthy Chinese Subjects: A Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study
    Li, Haiyan
    Wei, Yudong
    Yang, Zhenhua
    Zhang, Shuang
    Xu, Xiuxiu
    Shuai, Mengmeng
    Vitse, Olivier
    Wu, Yiwen
    Baccara-Dinet, Marie T.
    Zhang, Yi
    Li, Jianyong
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2020, 20 (05) : 489 - 503
12345